Institutional Ownership Prelude Therapeutics Inc (PRLD)
This table provides information about the institutional ownership of Prelude Therapeutics Inc (PRLD). We have compiled data on the 59 institutions that hold shares in the stock, with a total of 30.4 Million shares, which have been reported (via 13F filing form) to have a value of $26.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
10,909,256
shares
|
$9.05 Million
0.38% of portfolio
|
Q2 2023
Added 8.66%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
10,123,824
shares
|
$8.4 Million
0.14% of portfolio
|
Q1 2021
Added 0.05%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,068,916
shares
|
$887,200
0.0% of portfolio
|
Q2 2024
Reduced 2.6%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,029,199
shares
|
$854,235
0.0% of portfolio
|
Q4 2024
Reduced 6.23%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
1,010,392
shares
|
$838,625
0.0% of portfolio
|
Q4 2024
Reduced 1.11%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
666,574
shares
|
$553,256
0.0% of portfolio
|
Q4 2024
Added 280.95%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
634,500
shares
|
$526,635
0.0% of portfolio
|
Q4 2024
Added 222.24%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Feb 12, 2025 Q4 2024 |
494,497
shares
|
$410,432
0.0% of portfolio
|
Q4 2024
Reduced 10.01%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
485,381
shares
|
$402,866
0.0% of portfolio
|
Q4 2024
Added 554.66%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
462,555
shares
|
$383,920
0.0% of portfolio
|
Q4 2024
Added 188.15%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
402,336
shares
|
$333,938
0.0% of portfolio
|
Q4 2024
Added 2.71%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
392,155
shares
|
$325,488
0.0% of portfolio
|
Q4 2024
Added 9.19%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
365,159
shares
|
$303,081
0.0% of portfolio
|
Q4 2024
Added 12.81%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
300,000
shares
|
$249,000
0.0% of portfolio
|
Q4 2024
Added 526.3%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
293,396
shares
|
$243,518
0.0% of portfolio
|
Q4 2024
Added 2.57%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
231,839
shares
|
$192,426
0.0% of portfolio
|
Q4 2024
Added 307.21%
|
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
166,830
shares
|
$138,468
0.0% of portfolio
|
Q4 2024
Added 1289.79%
|
|
|
Td Asset Management Inc
|
Feb 11, 2025 Q4 2024 |
160,652
shares
|
$133,341
0.0% of portfolio
|
Q3 2023
Added 100.0%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
148,326
shares
|
$123,110
0.0% of portfolio
|
Q4 2024
Added 55.87%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
123,899
shares
|
$102,836
0.0% of portfolio
|
Q4 2024
Added 747.58%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
117,200
shares
|
$97,276
0.0% of portfolio
|
Q4 2024
Reduced 12.04%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
111,000
shares
|
$92,130
0.0% of portfolio
|
Q4 2024
Reduced 36.97%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
83,387
shares
|
$69,211
0.0% of portfolio
|
Q4 2024
Reduced 21.61%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
72,799
shares
|
$60,423
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
70,045
shares
|
$58,137
0.0% of portfolio
|
Q2 2024
Reduced 3.07%
|